why choose us

First received: November 30, 2022

Clinical Trial: Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary Fibrosis

Study Status: Completed

Recruit Status: Completed

Condition: Post-COVID-19 Syndrome
Lung Fibrosis

Study Type: Observational


Official Title: Impact of Anti-Inflammatory and Anti-Fibrotic Drugs on Post-acute COVID-19 Pulmonary Fibrosis

Brief Summary: In this study we aim to evaluate the radiological and functional changes in post-acute covid-19 pulmonary fibrosis patients in relation to anti-inflammatory and/or antifibrotic drugs prescribed during and after covid-19 pneumonia.

Read more